Arkolith/Insider Trading/TENX/Form 4

Rich Stuart

Chief Medical Officer, DirectorTENAX THERAPEUTICS, INC. (TENX) · full profile →Form 4 · filed Dec 10, 2025
Net Buying
Open-Market Buys
$51K
Open-Market Sells
$0
Net Open-Market Flow
$51K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2025Buy(P)3K$10.22$26K5K
Dec 8, 2025Buy(P)3K$10.10$25K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001841785-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML